24 May 2013
Keywords: impact, generics, usa, overview, merrill, lynch, pharmaceutical
Article | 19 May 2003
Pharmaceutical manufacturers in the USA face two major challenges: a wave of major product patent expirations in 2006/7 and litigation that
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 May 2003
23 May 2013
© 2013 thepharmaletter.com